RFK Jr. remains firmly entrenched as HHS Secretary due to sustained White House alignment on MAHA priorities, vaccine schedule revisions, and department reorganization. As of mid-September 2026, he continues active policy leadership, including leadership team adjustments, AI initiatives in Medicare and FDA pathways, and public appearances such as his keynote at the Children's Health Defense conference. Senate proceedings for deputy and assistant secretary nominees proceed without disruption, and no official statements or credible reports signal impending resignation or removal. Trader consensus at 94.5% for "No" reflects the absence of political catalysts that would force an exit before October 31, consistent with historical patterns of cabinet stability under unified administration support.